Olimpia Musumeci

Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

Olimpia Musumeci, Ali Naini, Alfred E. Slonim et al. · Neurology · 2001 · 252 citations

Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson’s Disease Models

Angelo Iannielli, Simone Bido, Lucrezia Folladori et al. · Cell Reports · 2018 · 225 citations · Full text

Syndromic parkinsonism and dementia associated with <scp> <i>OPA</i> </scp> <i>1</i> missense mutations

Valério Carelli, Olimpia Musumeci, Leonardo Caporali et al. · Annals of Neurology · 2015 · 184 citations · Full text

Phenotypic heterogeneity of the 8344A&gt;G mtDNA “MERRF” mutation

Michelangelo Mancuso, Daniele Orsucci, C. Angelini et al. · Neurology · 2013 · 170 citations

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3